FERRARI, Silvia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.662
EU - Europa 3.347
AS - Asia 3.135
SA - Sud America 398
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 69
OC - Oceania 5
Totale 17.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.470
GB - Regno Unito 1.590
SG - Singapore 912
CN - Cina 857
HK - Hong Kong 422
IT - Italia 343
BR - Brasile 307
SE - Svezia 262
FI - Finlandia 250
DE - Germania 248
VN - Vietnam 246
BD - Bangladesh 201
UA - Ucraina 190
TR - Turchia 175
FR - Francia 145
RU - Federazione Russa 138
CA - Canada 93
BG - Bulgaria 66
KR - Corea 49
ID - Indonesia 41
IN - India 40
AE - Emirati Arabi Uniti 34
AR - Argentina 32
MX - Messico 31
ZA - Sudafrica 29
NL - Olanda 27
EC - Ecuador 22
PK - Pakistan 22
JP - Giappone 20
IQ - Iraq 18
ES - Italia 15
PL - Polonia 15
IL - Israele 14
CO - Colombia 13
TT - Trinidad e Tobago 12
IE - Irlanda 11
NP - Nepal 11
CL - Cile 10
BZ - Belize 9
MY - Malesia 9
UZ - Uzbekistan 9
VE - Venezuela 9
EG - Egitto 8
SA - Arabia Saudita 8
HN - Honduras 7
PH - Filippine 7
GT - Guatemala 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
RO - Romania 6
SC - Seychelles 6
SV - El Salvador 6
TH - Thailandia 6
BY - Bielorussia 5
CH - Svizzera 5
MA - Marocco 5
AU - Australia 4
BE - Belgio 4
CW - ???statistics.table.value.countryCode.CW??? 4
DK - Danimarca 4
HU - Ungheria 4
KZ - Kazakistan 4
LT - Lituania 4
TW - Taiwan 4
AZ - Azerbaigian 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
LB - Libano 3
PR - Porto Rico 3
SN - Senegal 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BB - Barbados 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GP - Guadalupe 2
HT - Haiti 2
IR - Iran 2
KG - Kirghizistan 2
MN - Mongolia 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
CI - Costa d'Avorio 1
Totale 17.612
Salva come PNG Salva come JPEG
Città #
Southend 1.275
Ashburn 1.037
Fairfield 911
Santa Clara 829
Woodbridge 589
Singapore 580
Chicago 496
Hong Kong 417
Jacksonville 390
Houston 354
Seattle 343
Los Angeles 328
San Jose 313
Chandler 296
Council Bluffs 285
Cambridge 283
Wilmington 282
Dearborn 225
Ann Arbor 217
Salt Lake City 206
Hefei 194
Helsinki 190
Nyköping 184
Beijing 178
London 168
Izmir 113
New York 98
Tampa 94
Elk Grove Village 92
Ho Chi Minh City 80
The Dalles 75
Princeton 70
San Diego 65
Sofia 65
Bremen 62
Modena 61
Dallas 58
Eugene 58
Hanoi 58
Columbus 56
Lauterbourg 53
Sterling 50
Buffalo 48
Milan 48
Seoul 48
Boardman 47
Lancaster 46
Frankfurt am Main 37
Phoenix 37
São Paulo 37
Miami 34
Shanghai 34
Moscow 32
Dulles 29
Detroit 28
Jakarta 28
Atlanta 27
Des Moines 26
Toronto 25
Reading 20
North Bergen 18
Redwood City 17
Rome 17
Brooklyn 16
Da Nang 16
Kansas City 16
Mexico City 15
Saint Augustine 15
Tokyo 15
Dong Ket 14
Montreal 14
Warsaw 14
Kunming 13
Guangzhou 12
Haiphong 12
Norwalk 12
Orem 12
Chiswick 11
Curitiba 11
Dublin 11
Pittsburgh 11
Denver 10
Hangzhou 10
Hounslow 10
Jersey City 10
Newark 10
Belize City 9
Kilburn 9
Queens 9
Turin 9
Charlotte 8
Johannesburg 8
Lahore 8
San Francisco 8
Tashkent 8
Baghdad 7
Belo Horizonte 7
Delhi 7
Miano 7
Philadelphia 7
Totale 12.862
Salva come PNG Salva come JPEG
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 778
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 481
Endocrine manifestations of hepatitis C virus infection. 407
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 397
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 392
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 386
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 386
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 380
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 366
Cytokines and HCV-related disorders 358
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 357
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 355
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 352
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 350
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 344
Associations between Systemic Sclerosis and Thyroid Diseases 342
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 341
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 335
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 320
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 315
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 314
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 311
[CXCR3 and CXCL10 in autoimmune thyroiditis] 309
IP-10 in autoimmune thyroiditis 298
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 296
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 295
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 294
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 291
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 291
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 287
New targeted molecular therapies for dedifferentiated thyroid cancer 286
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 279
[Cryoglobulinemia and the α-chemokine IP-10] 274
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 274
Novel Therapies for Thyroid Autoimmune Diseases 267
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 265
RET TKI: potential role in thyroid cancers. 262
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 260
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 246
CXCL10 in psoriasis 246
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 238
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 236
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 235
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 235
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 226
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 225
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 222
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 219
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 215
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 213
α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis 210
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 207
Role of CXCL10 in cryoglobulinemia 195
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 185
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 180
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 176
HCV-related autoimmune disorders in HCV chronic infection. 172
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 170
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 166
Mixed cryoglobulinemia and thyroid autoimmune disorders 152
Hepatitis C virus infection and type 2 diabetes. 145
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 132
Totale 17.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022666 0 0 0 0 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/20252.262 64 13 19 188 529 376 73 124 286 205 188 197
2025/20265.738 177 144 295 958 1.690 330 466 188 439 345 386 320
2026/20271.341 156 219 294 555 117 0 0 0 0 0 0 0
Totale 17.741